References
- Bechan S, Devendra KR, Prashant KR, Rizvi SI, Geeta W. (2010). Determination of erythrocyte fragility as a marker of pesticide-induced membrane oxidative damage. Methods Mol Biol594: 123–128.
- Bekemeier H, Leuschner G, Schmollack W. (1967). Antipyretic, antiedematous and analgetic effects of damascenine in comparison with acetylsalicylic acid and phenylbutazone. Arch Int Pharmacodyn Ther168(1): 199–211.
- Bouguezza Y, Bribi N, Tacherfiout M, Amara S, Khettal B. (2013). Acute and sub-chronic toxicity study of Nigella damascena methanolic seed extract in mice. Int J Pharm Bio Sci4(2): 413–419.
- Döpke W, Fritsch G. (1970). Der Alkaloidgehalt von Nigella damascena L. Pharmazie25: 69–70.
- Edward AL, Celia JR. (1998). Xenobiotic Metabolizing Enzymes of the Kidney. Toxicologic Pathology26(1): 18–25.
- Emerson FS, Shadara AC, Devi PU. (1993). Toxic effects of crude extract of Plumbago rosea (Rokta chitraka). J Ethnopharmacol38: 79–84.
- Ewins AJ. (1912). LXII. –The constitution and synthesis of damascenine, the alkaloid of Nigella damascena. J Chem Soc, Trans101: 544–552.
- Fico G, Tomè F. (1998). Akaloids content in the ripening seeds of Nigella damascena. Europ J Pharmaceutical Sci 6(Suppl 1): S79.
- Fico G, Panizzi L, Flamini G, Braca A, Morelli I, Tomè F, Cioni PL. (2004). Biological screening of Nigella damascena for antimicrobial and molluscicidal activities. Phytother Res18(6): 468–470.
- Kew MC. (2000). Serum aminotransferase concentration as evidence of hepatocellular damage. Lancet355(9204): 591–2.
- Liangyou R. (2014). Energy metabolism in the liver. Compr Physiol4(1): 177–197.
- Mohan LV, Mothes K, Engelbrecht L, Schroter HB. (1965). Biosynthesis of damascenine in Nigella damascena L. Nature12: 1421–1428.
- Necyk C, Tsuyuki RT, Boon H, Foster BC, et al. (2014). Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality. BMJ Open4(3): e003431.
- OECD, Test guideline 407. (2008). Repeated dose oral toxicity test method. In: Organization for Economic Cooperation and Development. Section 4-Health Effects, Paris, France.
- Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. (2008). The current state of serum biomarkers of hepatotoxicity. Toxicology245: 194–205.
- Sener G, Sehirli AO, Altunbas H.Z, Ersoy Y, Paskaloglu KA, Ayanoglu-Dugler G. (2002). Melatonin protects against gentamicin induced nephrotoxicity in rats. J Pineal Res32: 231–236.
- Sirwal IA, Banday KA, Reshi AR, Bhat MA, Wani MM. (2004). Estimation of Glomerular Filteration Rate (GFR). JK Science6: 121–123.
- Stillman AE. (1990). Jaundice, in Clinical Methods: The History, Physical, and Laboratory Examinations (3rd edition, Walker HK, Hall WD, Hurst JW, editors) pp. 448–456.
- Udem SC, Obidoa O, Asuzu IU. (2009). Acute and chronic toxicity studies of Erythrina senegalensis DC stem bark extract in mice. Comp Clin Pathol19: 275–282.
- Valdiguié P. (2000). Constituant azotés non protéique, in Biochimie Clinique (2èmeed Médicales Internationales) pp. 267, Cedex.
- Vohra S, Cvijovic K, Boon H, Foster BC et al. (2012). Study of natural health product adverse reactions (SONAR): active surveillance of adverse events following concurrent natural health product and prescription drug use in community pharmacies. PLOS ONE7(9): e45196.
- Wyss M, Kaddurah-Daouk R. (2000). Creatine and creatinine metabolism. Physiol Rev80(3): 1107–213.
- Xian-guo HE, Ursula M. (1994). Antifungal compound from Solanum nigrescens. J Ethnopharmacol43: 173–17.